AU3924500A - Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine - Google Patents

Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine

Info

Publication number
AU3924500A
AU3924500A AU39245/00A AU3924500A AU3924500A AU 3924500 A AU3924500 A AU 3924500A AU 39245/00 A AU39245/00 A AU 39245/00A AU 3924500 A AU3924500 A AU 3924500A AU 3924500 A AU3924500 A AU 3924500A
Authority
AU
Australia
Prior art keywords
descarboethoxyloratadine
fluorinated
compositions
methods
related disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39245/00A
Inventor
Evgeny Aronov
Anatoliy Khusid
John J. Piwinski
Doris P. Schumacher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU3924500A publication Critical patent/AU3924500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU39245/00A 1999-03-29 2000-03-27 Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine Abandoned AU3924500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28111599A 1999-03-29 1999-03-29
US09281115 1999-03-29
PCT/US2000/008080 WO2000057880A1 (en) 1999-03-29 2000-03-27 Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine

Publications (1)

Publication Number Publication Date
AU3924500A true AU3924500A (en) 2000-10-16

Family

ID=23076010

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39245/00A Abandoned AU3924500A (en) 1999-03-29 2000-03-27 Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine

Country Status (2)

Country Link
AU (1) AU3924500A (en)
WO (1) WO2000057880A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1209151T3 (en) 1999-09-01 2007-08-20 Eisai R&D Man Co Ltd 4-SUBSTITUTED PIPERIDE INGREDIATES
DE60139781D1 (en) * 2000-06-21 2009-10-15 Eisai R&D Man Co Ltd 4-SUBSTITUTED PIPERIDINE COMPOUND

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863931A (en) * 1988-09-15 1989-09-05 Schering Corporation Antihistaminic fluoro substituted benzocycloheptapyridines
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
AU732671B2 (en) * 1996-02-08 2001-04-26 Merck & Co., Inc. Method of treatment and pharmaceutical composition
CO4910128A1 (en) * 1996-10-31 2000-04-24 Schering Corp ASTHMA TREATMENT AND USEFUL COMPOUNDS FOR THIS COMBINATION TREATMENT AND A KIT OF THIS COMBINATION

Also Published As

Publication number Publication date
WO2000057880A1 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
EP1005345A4 (en) Methods and compositions for treating allergic asthma and other disorders using descarboethoxyloratadine
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU8003800A (en) Methods and compositions for treating neurobehavioral disorders
AU2001245437A1 (en) Lightweight methods and compositions for well treating
AU2003238561A1 (en) Compositions and methods for treating gynaecological disorders
AU5309400A (en) Methods and compositions for the treatment of neuroleptic and related disorders using sertindole derivatives
EP1229930A4 (en) Compositions and methods for treatment of allergic disorders
AU4340700A (en) Methods and compositions for use in the treatment of hyperlipidemia
AU5601300A (en) Method and compositions for treating and preventing retinal damage
AU2002367023A1 (en) Compositions and methods for treating heart failure
WO2003039490A9 (en) Compositions and methods for diagnosing and treating mental disorders
AU2002365057A1 (en) Compositions and methods for treating heart failure
AU4511201A (en) Compositions and methods for the induction and treatment of retinal detachments
AU1953701A (en) Methods and compositions for treatment of inflammatory disease
AU2001264522A1 (en) Methods and compositions for the prevention of myopia
AU6252699A (en) Composition and method for treating allergic diseases
AU2003214920A1 (en) Methods and compositions for treating hematological disorders
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU3924500A (en) Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
AU4660700A (en) Surface care compositions and methods for treating surfaces
AU2003275433A1 (en) Compositions and methods for treating pain
AU2002363228A1 (en) Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750
AUPQ872800A0 (en) Compositions and methods for treating cardiovascular disorders
AU2002217915A1 (en) Compositions and methods for diagnosing or treating psoriasis
AU2002342188A1 (en) Methods and compositions for treating flavivirus-mediated disease

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase